Synchron has achieved a breakthrough in assistive technology by enabling an ALS patient, Mark Jackson, to control an iPad using only his thoughts, facilitated by the Stentrode, an FDA-approved brain-computer interface (BCI). This innovative endovascular electrode array captures brain signals without invasive surgery, translating thoughts into digital actions to enhance device accessibility for individuals with paralysis. The BCI system's compatibility with Apple's Switch Control and the newly released BCI Human Interface Device standard underscores its potential to improve interaction with technology for disabled users. This development marks a significant step forward in the integration of advanced technology into everyday healthcare solutions, improving quality of life for patients with severe mobility challenges.